The revised EU pharmaceutical policy maintains eight-year data protection but reduces market protection to one year, ...

In an age when antibiotic resistance poses a severe threat to global health, a new study sheds light on the often-overlooked hurdles of drug commercialization. Soaring costs associated with bringing ...

An ad hoc committee will plan and host a 1.5-day public workshop to facilitate discussion focused on the translation of federal investments in biomedical science to innovation in drug development and ...

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

In the rapidly evolving field of pharmaceuticals, China's role as a hub for innovative drug development continues to expand, particularly in its outbound strategies. As we approach the end of 2025, ...

As clinical research evolves, disruptive trial designs are reshaping how oncology advances. By integrating novel ...

A survey has found that China, which is rapidly growing in the bio sector including the discovery of new drug candidates, is set to rise to become one of the world’s top three innovative drug markets.

AdAlta Ltd. (AU:1AD) has released an update. AdAlta Limited is set to showcase its innovative i-body drug discovery platform at the TSN Emerging ASX Gems Investment Conference, highlighting ...

CAMBRIDGE, England & DONGGUAN, China--(BUSINESS WIRE)--Apollo Therapeutics Group Limited (“Apollo”), the portfolio biopharmaceutical company, and Sunshine Lake Pharma Co., Ltd. (“Sunshine Lake”), an ...